Diasorin: Your Partner in Market Access
By Bridget Parsons
Market Access supports lab decision making with strategic insight
When a new molecular test comes on the market, clinical validity and turnaround time are often the first aspects most labs consider. However, these additional considerations matter just as much:
- Will we be reimbursed for running this assay?
- Would our providers actually order it?
- Can running this test be financially sustainable, or would we lose money running it?
This is where Market Access comes in.
What is Market Access, and why does it matter?
Market Access refers to how tests gain coverage, reimbursement, and broader adoption across healthcare systems. Even if you’re not directly negotiating with insurance providers, Market Access directly affects many aspects of your work, including:
- Your bottom line: Denials and low reimbursement lead to time consuming appeals and ultimately lost revenue.
- Operational confidence: If a test is seen as high-risk for denial from insurance providers, it’s more difficult to justify ordering it.
- Patient and provider satisfaction: Providers want to offer tests that are covered by insurance and won’t lead to high bills for their patients.
Market Access guidance supports success
With tightening budgets, evolving coverage policies, and increasing demands on labs to prove value as well as performance, Market Access is no longer a downstream issue; it’s part of the adoption conversation from the start.
Market Access consultation can help labs better address the following:
- Reimbursement clarity
Labs are increasingly cautious about adding new tests, especially if CPT coding is unclear or denial rates are high. A test with clear billing guidance and support is much easier to greenlight than one without. - Test utilization strategy
Tests that let you choose the right panel size or adapt to clinical questions help your lab align better with payer expectations. That flexibility can reduce unnecessary denials and increase clinician satisfaction. - Workflow efficiency
If a new test streamlines sample handling, integrates easily with the laboratory/hospital information system (LIS/HIS), or reduces instrument clutter, it’s a win for everyone involved. However, it’s only sustainable if the reimbursement supports the investment. - Support from commercial partners
Diasorin offers reimbursement education, coding support, reimbursement appeal templates, and more to reduce your lab’s financial risk and administrative burden.
At Diasorin, providing a testing solution is only the beginning of the relationship. We stay in the trenches with our customers to navigate the complex realities of coding, coverage, and reimbursement. Our Market Access team works side-by-side with your lab to anticipate payer requirements, provide practical reimbursement tools, and equip your staff with the knowledge to maximize coverage and minimize denials. This hands-on approach is a differentiator in the diagnostics industry—because we know that your success isn’t just about clinical performance, it’s about ensuring the test you run is also one you get paid for.
Partner with our Market Access team to explore smarter solutions
Market Access may not be in your job title, but it’s in your day-to-day reality. A great test is only part of the equation. The rest is about knowing you’ll be supported—not just clinically, but operationally and financially.
Interested in receiving Market Access guidance for your lab? Here are the next steps for you to consider:
- Review coding and coverage, not just reimbursement rates for tests before you commit.
- Talk to your commercial partners about what education, support, and reimbursement resources they provide.
- Start conversations early to ensure you align your clinical, operational, reimbursement strategy proactively.
To explore how our solutions fit your clinical and economic goals, reach out to our team at MarketAccess@diasorin.com to schedule a consultation today.
Read more from our Market Access team:
Dialog 